Ratos: Interim report January-September 2012

This information is disclosed in accordance with the Securities Markets Act, the
    Financial Instruments Trading Act or demands made in the exchange rules.

  * Profit before tax SEK 1,056m (935)
  * Profit before tax, adjusted for items affecting comparability and exit gains
    SEK 612m (680)
  * Earnings per share before dilution SEK 3.04 (2.21)
  * Mixed development in the holdings
  * Anticimex and Lindab sold - exit gain SEK 979m
  * Agreement to sell Stofa - exit gain approximately SEK 850m
  * Total return on Ratos shares -23%


Telephone conference today at 10.00 a.m. CET, tel +46 8 505 201 10.


Stockholm 9 November 2012
Ratos AB (publ)


For further information, please contact:
Susanna Campbell, CEO, +46 8 700 17 00
Emma Rheborg, Head of Corporate Communications and IR, +46 8 700 17 20


Financial calendar from Ratos:

 Year-end report 2012                    15 February 2013

 Annual General Meeting 2013             17 April 2013

 Interim Report January - March 2013     8 May 2013

 Interim Report January - June 2013      15 August 2013

 Interim Report January - September 2013 8 November 2013





Ratos is a private equity conglomerate. The company's mission is to maximise
shareholder value over time through the professional, active and responsible
exercise of its ownership role in primarily medium to large unlisted Nordic
companies. Ratos's holdings include AH Industries, Arcus-Gruppen, Biolin
Scientific, Bisnode, Contex, DIAB, Euromaint, Finnkino, GS-Hydro, Hafa Bathroom
Group, HL Display, Inwido, Jøtul, KVD Kvarndammen, Mobile Climate Control,
SB Seating and Stofa. Ratos is listed on Nasdaq OMX Stockholm and market
capitalisation amounts to approximately SEK 19 billion.